These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12561770)

  • 1. Taking cardiovascular risk factors to heart.
    Clark WL
    Diabetes Self Manag; 2002; 19(6):60-2, 64. PubMed ID: 12561770
    [No Abstract]   [Full Text] [Related]  

  • 2. POPADAD trial. Don't stop taking aspirin.
    Elwood P
    BMJ; 2008 Nov; 337():a2581. PubMed ID: 19019864
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
    Price HC; Holman RR
    Nat Clin Pract Cardiovasc Med; 2009 Mar; 6(3):168-9. PubMed ID: 19153560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
    [No Abstract]   [Full Text] [Related]  

  • 5. An aspirin a day: are we barking up the wrong willow tree?
    Krantz MJ; Berger JS; Hiatt WR
    Pharmacotherapy; 2010 Feb; 30(2):115-8. PubMed ID: 20099985
    [No Abstract]   [Full Text] [Related]  

  • 6. POPADAD trial. Time for a proper study of aspirin after a vascular event?
    Cleland JG
    BMJ; 2008 Nov; 337():a2583. PubMed ID: 19019865
    [No Abstract]   [Full Text] [Related]  

  • 7. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
    Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract]   [Full Text] [Related]  

  • 8. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of cardiovascular events in diabetes.
    Sigal R; Malcolm J; Arnaout A
    Clin Evid; 2006 Jun; (15):623-45. PubMed ID: 16973029
    [No Abstract]   [Full Text] [Related]  

  • 10. Can the time of taking aspirin influence the frequency of cardiovascular events?
    Kriszbacher I; Ajtay Z; Koppán M; Bódis J
    Am J Cardiol; 2005 Aug; 96(4):608-10. PubMed ID: 16098324
    [No Abstract]   [Full Text] [Related]  

  • 11. A study of aspirin resistance in type 2 diabetes.
    Singla MK; Lahiri P; Mukhopadhyay P; Pandit K; Chaudhuri U; Chowdhury S
    J Indian Med Assoc; 2008 Nov; 106(11):720, 722-3, 740. PubMed ID: 19368097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention in the 21st century. Athero-thrombosis and ischemic events].
    Z Kardiol; 1998 Nov; 87(11 Suppl Atherothro):1-3. PubMed ID: 9883501
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin for primary prevention in patients with diabetes mellitus.
    Nguyen KX; Marinac JS; Sun C
    Fam Med; 2005 Feb; 37(2):112-7. PubMed ID: 15690251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of cardiovascular events and type 2 diabetes: should we prioritize our interventions?
    Sultan A; Thuan JF; Avignon A
    Diabetes Metab; 2006 Dec; 32(6):559-67. PubMed ID: 17296509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of aspirin in diabetic patients].
    Türkoğlu S; Abaci A
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():5-8. PubMed ID: 18160360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Daily low dose aspirin for patients in high risk].
    Born GV
    Rev Med Suisse; 2007 May; 3(113):1400. PubMed ID: 17645054
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of cardiovascular events in diabetes.
    Malcolm J; Meggison H; Sigal R
    Clin Evid; 2003 Dec; (10):690-714. PubMed ID: 15555116
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.
    Blinc A; Poredos P
    Eur J Clin Invest; 2007 Mar; 37(3):157-64. PubMed ID: 17359482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin resistance: is it real? Is it clinically significant?
    Dalen JE
    Am J Med; 2007 Jan; 120(1):1-4. PubMed ID: 17208069
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose aspirin for primary prevention of cardiovascular disease.
    Bredie SJ; Wollersheim H; Verheugt FW; Thien T
    Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.